165 related articles for article (PubMed ID: 31464316)
1. Lactobacillus casei LC2W can inhibit the colonization of Escherichia coli O157:H7 in vivo and reduce the severity of colitis.
Wang G; Zhang Y; Song X; Xia Y; Lai PF; Ai L
Food Funct; 2019 Sep; 10(9):5843-5852. PubMed ID: 31464316
[TBL] [Abstract][Full Text] [Related]
2. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
[TBL] [Abstract][Full Text] [Related]
3. Magnesium Sensing Regulates Intestinal Colonization of Enterohemorrhagic Escherichia coli O157:H7.
Liu Y; Han R; Wang J; Yang P; Wang F; Yang B
mBio; 2020 Nov; 11(6):. PubMed ID: 33173003
[TBL] [Abstract][Full Text] [Related]
4. Cathelicidin- derived PR39 protects enterohemorrhagic Escherichia coli O157:H7 challenged mice by improving epithelial function and balancing the microbiota in the intestine.
Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Beibei W; Jifeng Z; Xuemei W; Kebang W
Sci Rep; 2019 Jul; 9(1):9456. PubMed ID: 31263234
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a Direct-Fed Microbial Product Containing
Dewsbury DMA; Cernicchiaro N; Depenbusch B; Nagaraja TG; Renter DG
Foodborne Pathog Dis; 2021 Jan; 18(1):16-23. PubMed ID: 32898446
[TBL] [Abstract][Full Text] [Related]
6. Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.
Sanchez-Villamil JI; Tapia D; Torres AG
mBio; 2019 Aug; 10(4):. PubMed ID: 31409688
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
[TBL] [Abstract][Full Text] [Related]
8. Oral Administration of Bovine Lactoferrin-Derived Lactoferricin (Lfcin) B Could Attenuate Enterohemorrhagic Escherichia coli O157:H7 Induced Intestinal Disease through Improving Intestinal Barrier Function and Microbiota.
Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Jifeng Z; Xuemei W; Beibei W
J Agric Food Chem; 2019 Apr; 67(14):3932-3945. PubMed ID: 30892034
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves.
Dean-Nystrom EA; Bosworth BT; Cray WC; Moon HW
Infect Immun; 1997 May; 65(5):1842-8. PubMed ID: 9125570
[TBL] [Abstract][Full Text] [Related]
10. [Estimation of probiotics by infection model of infant rabbit with enterohemorrhagic Escherichia coli O157:H7].
Tachikawa T; Seo G; Nakazawa M; Sueyoshi M; Ohishi T; Joh K
Kansenshogaku Zasshi; 1998 Dec; 72(12):1300-5. PubMed ID: 9916417
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice.
Lin R; Zhu B; Zhang Y; Bai Y; Zhi F; Long B; Li Y; Wu Y; Wu X; Fan H
Microb Pathog; 2017 Apr; 105():19-24. PubMed ID: 28163157
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains.
Mogna L; Del Piano M; Deidda F; Nicola S; Soattini L; Debiaggi R; Sforza F; Strozzi G; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S29-32. PubMed ID: 22955353
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulating activity of Lactobacillus paracasei subsp. paracasei NTU 101 in enterohemorrhagic Escherichia coli O157H7-infected mice.
Tsai YT; Cheng PC; Pan TM
J Agric Food Chem; 2010 Nov; 58(21):11265-72. PubMed ID: 20942489
[TBL] [Abstract][Full Text] [Related]
14. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice.
Gagnon M; Kheadr EE; Dabour N; Richard D; Fliss I
Int J Food Microbiol; 2006 Aug; 111(1):26-33. PubMed ID: 16822570
[TBL] [Abstract][Full Text] [Related]
15. Adhesion and colonization of enterohemorrhagic Escherichia coli O157:H7 in cecum of mice.
Nagano K; Taguchi K; Hara T; Yokoyama S; Kawada K; Mori H
Microbiol Immunol; 2003; 47(2):125-32. PubMed ID: 12680715
[TBL] [Abstract][Full Text] [Related]
16. Mutation of toxB and a truncated version of the efa-1 gene in Escherichia coli O157:H7 influences the expression and secretion of locus of enterocyte effacement-encoded proteins but not intestinal colonization in calves or sheep.
Stevens MP; Roe AJ; Vlisidou I; van Diemen PM; La Ragione RM; Best A; Woodward MJ; Gally DL; Wallis TS
Infect Immun; 2004 Sep; 72(9):5402-11. PubMed ID: 15322038
[TBL] [Abstract][Full Text] [Related]
17. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
[TBL] [Abstract][Full Text] [Related]
18. Competition for proline between indigenous Escherichia coli and E. coli O157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coli O157:H7.
Momose Y; Hirayama K; Itoh K
Antonie Van Leeuwenhoek; 2008 Aug; 94(2):165-71. PubMed ID: 18247153
[TBL] [Abstract][Full Text] [Related]
19. Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats.
Lee JH; Regmi SC; Kim JA; Cho MH; Yun H; Lee CS; Lee J
Infect Immun; 2011 Dec; 79(12):4819-27. PubMed ID: 21930760
[TBL] [Abstract][Full Text] [Related]
20. Effect of organic acids on inhibition of Escherichia coli O157:H7 colonization in gnotobiotic mice associated with infant intestinal microbiota.
Momose Y; Hirayama K; Itoh K
Antonie Van Leeuwenhoek; 2008; 93(1-2):141-9. PubMed ID: 17674138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
